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Stress adaptation is essential for neuronal health.
While the fundamental role of mitochondria in
neuronal development has been demonstrated, it is
still not clear howadult neurons respond toalterations
in mitochondrial function and how neurons sense,
signal, and respond to dysfunction of mitochondria
and their interacting organelles. Here, we show that
neuron-specific, inducible in vivo ablation of themito-
chondrial fission protein Drp1 causes ER stress, re-
sulting in activation of the integrated stress response
to culminate in neuronal expression of the cytokine
Fgf21. Neuron-derived Fgf21 induction occurs also
in murine models of tauopathy and prion disease,
highlighting the potential of this cytokine as an early
biomarker for latent neurodegenerative conditions.INTRODUCTION
In neurons, mitochondrial fission, which in mammals depends
mainly on dynamin-related protein Drp1, facilitates both axonal
mitochondrial transport andmitophagic elimination (Oettinghaus
et al., 2016; Pernas and Scorrano, 2016; Twig et al., 2008; Wai
and Langer, 2016). Not surprisingly, Drp1 is therefore required
for brain development and mature neuronal function (Berthet
et al., 2014; Ishihara et al., 2009; Kageyama et al., 2012; Oetting-
haus et al., 2016; Shields et al., 2015; Wakabayashi et al., 2009).
In several clinically and pathologically distinct neurodegenera-
tive diseases, mitochondrial morphology is disrupted (reviewedCell
This is an open access article under the CC BY-Nby DuBoff et al., 2013), substantiating the link among mitochon-
drial dynamics, function, and brain pathophysiology. Given this,
brain mitochondrial dysfunction could represent an important
marker to identify subjects at risk of developing neurodegenera-
tive disorders, before neurological symptoms manifest; how-
ever, no surrogate marker of brain mitochondrial dysfunction is
available.
Mitochondria of peripheral organs (e.g., liver and muscle) can
convey disruption of their function by mounting cell-wide stress
responses (Cornu et al., 2014; Guridi et al., 2015; Hagiwara et al.,
2012; Keipert et al., 2014; Kim et al., 2013a; Touvier et al., 2015;
Tyynismaa et al., 2010). A common trait of these models is the
expression, causally linked to mitochondrial dysfunction, of the
metabolic cytokine fibroblast growth factor 21 (Fgf21). This cyto-
kine exerts a plethora of tissue-specific effects and is subject
to complex pharmacology and pharmacokinetics, aspects of
which continue to be matter of debate (reviewed by Kharitonen-
kov and DiMarchi, 2017). In addition to being canonically pro-
duced by liver and white adipose tissue (WAT) in response to
starvation, Fgf21 can be secreted by other organs, such as
pancreas and brown adipose tissue (Degirolamo et al., 2016;
Fisher and Maratos-Flier, 2016). Moreover, Fgf21 has been es-
tablished as amarker ofmitochondrial myopathies (Suomalainen
et al., 2011; Tezze et al., 2017). Whether Fgf21 is also produced
by the CNS in response to mitochondrial dysfunction is un-
known. Here we capitalize on our previously generated mouse
model of inducible mitochondrial fission ablation in mature fore-
brain neurons (Oettinghaus et al., 2016), as well as on bona
fide mouse models of neurodegeneration, to demonstrate that
various forms of neuronal cell stress, including mitochondrial
dysfunction, are sensed by the integrated stress response
(ISR). In each of these models, ISR activation leads toReports 24, 1407–1414, August 7, 2018 ª 2018 The Authors. 1407
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Neuronal Drp1 Ablation Induces
ISR-Driven Brain Fgf21 Expression
(A) FGF21 plasma levels in cardiac blood of Drp1-
ablated and control mice. Positive control repre-
sents overnight-starved animals. Data represent
average + SEM of at least 3 animals.
(B) qRT-PCR analysis of different mouse tissues at
indicated time points PTI. Fgf21 mRNA ct values
normalized against 18S rRNA ct values. Data
represent average + SEM of at least 4 animals.
(C and D) Representative Fgf21 mRNA-fluores-
cence in situ hybridization (FISH) analysis of the
hippocampal CA1 region of aDrp1-ablatedmouse
at 10 weeks PTI (C). Fgf21 mRNA hybridization
signals are in green; nuclei are DAPI stained.
Scale bar, 20 mm. Quantification of hybridization
signals (D).
(E) Representative western blots of Drp1-ablated
and control hippocampal lysates separated by
SDS-PAGE and immunoblotted using indicated
antibodies.
(F and G) Quantification of phosphorylated elF2a
band intensity normalized to total elF2a (F) and
Atf4 intensity normalized to actin (G). Data repre-
sent average + SEM of at least 4 animals.
(H) qRT-PCR analysis of Chop expression in
various mouse brain regions. Data represent
average + SEM of at least 4 animals.neuron-specific Fgf21 expression, highlighting the potential of
this cytokine as biomarker for neurodegenerative conditions.
RESULTS
Neuronal Drp1 Ablation Activates the ISR, Resulting in
Fgf21 Induction
We previously generated a model of inducible ablation of the
mitochondrial fission protein Drp1 in the adult mouse forebrain
(Drp1flx/flx; CaMKIIa::CreERT2, tamoxifen-inducible Drp1 dele-
tion from brain,Drp1iDb/iDb). In thismodel, neuronalDrp1 ablation
compromised mitochondrial respiration and shifted cellular1408 Cell Reports 24, 1407–1414, August 7, 2018metabolism toward glycolysis (Oetting-
haus et al., 2016); in addition, sys-
temic catabolic changes occurred, which
prompted further investigation.
Because mitochondrial dysfunction in
several peripheral organs can lead to
the induction of the cytokine Fgf21 (Khar-
itonenkov and DiMarchi, 2015; Kim et al.,
2013a; Suomalainen et al., 2011), we
checked whether the same was true for
a brain-specific mitochondrial defect.
Starting 7weeks post-tamoxifen injection
(PTI, i.e., after Drp1 ablation), we found
elevated Fgf21 plasma levels (Figure 1A),
prompting us to investigate its source or-
gan or organs. Subsequent analyses re-
vealed that as early as 4 weeks after
Drp1 ablation, Fgf21 transcription was
induced specifically in hippocampusand cortex but not in: the cerebellum (where the Cre-driving
CaMKIIa promoter is inactive); the canonical Fgf21 sources (liver
and adipose tissue); or the skeletal muscle (Figure 1B). These re-
sults establish brain as the Fgf21 tissue source in our model.
mRNA fluorescence in situ hybridization identified neurons as
the primary Fgf21 producers in the Drp1-ablated mouse brain,
shown in Figures 1C and 1D for the hippocampal CA1 region
(Figures S1A–S1C detail the histological distribution of hippo-
campal pyramidal neurons for reference; for comparison, Fig-
ures S1D and S1E show the distribution of astrocytes andmicro-
glia). These observations are significant from two perspectives:
we demonstrate that Fgf21 can be produced by neurons in
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Figure 2. ER Stress Is Present and Suffi-
cient for Fgf21 Induction uponDrp1Ablation
(A) Representative transmission electron micro-
scopy (TEM) images of ER (marked by black
arrows) of hippocampal neurons of 4-week-Drp1-
ablated and control mice. Scale bar, 1 mm.
(B) Bip and actin western blot on hippocampal
lysates of mice of the indicated genotypes at
10 weeks PTI. This experiment shares a loading
control with Figure 1E.
(C) Quantification of Bip band intensity normalized
to actin. Data represent average + SEM of at least
4 animals.
(D–G) Markers of ER stress and Fgf21 levels in
brain tissue and plasma following intraventricular
tunicamycin (TUM) injection.
(D) Fgf21 mRNA in TUM- and Sham-injected
hippocampi.
(E and F) Representative western blot (E) and
quantification (F) of TUM- and Sham-injected
hippocampal lysates probed for the indicated
proteins. Data represent average + SEM of at least
3 animals.
(G) Fgf21 plasma levels as determined by ELISA.
Data represent average + SEMof at least 5 animals.response to mitochondrial dysfunction (Bookout et al., 2013;
Suomalainen et al., 2011; Fon Tacer et al., 2010) and that
Fgf21 produced in the brain can cross the blood-brain barrier
(BBB) to become detectable in plasma (Kharitonenkov and Di-
Marchi, 2015).
The ISR Is Activated upon Neuronal Drp1 Ablation
We next wished to understand how mitochondrial dysfunction
led to neuronal Fgf21 transcription. Among the transcription fac-
tors known to control Fgf21 expression, only Atf4 was upregu-
lated in Drp1-ablated brains (Figure S2A). Atf4 translation is acti-
vated by phosphorylated eukaryotic translation initiation factor
2a (eIF2a), a crucial node in the ISR, responding to different
forms of stress via decreased global translation and activation
of transcriptional programs aimed at damage control (Donnelly
et al., 2013). Western blot analysis confirmed Atf4 increase and
eIF2a phosphorylation in Drp1iDb/iDb hippocampi (Figures 1E–
1G). The canonical Atf4 target gene Chop (Ddit3 or Gadd153)
was accordingly upregulated in Drp1iDb/iDb hippocampus and
cortex (Figure 1H). Furthermore, proteomics revealed that Atf4
target genes were significantly enriched in Drp1iDb/iDb brains
(Figure S2B).
Four eIF2a kinases are capable of sensing specific ISR-trig-
gering stress conditions: Perk responds to endoplasmic retic-
ulum (ER) stress; Gcn2 acts as sensor for amino acid defi-Cell Reciency activated by uncharged tRNAs;
Pkr senses double-stranded RNAs to
signal viral infections and transduces
the mitochondrial unfolded protein
response (mtUPR) (Rath et al., 2012);
and HRI becomes activated in the
absence of heme (Donnelly et al.,
2013). In vivo, the eIF2a-phosphorylat-ing arm or arms of the ISR could not be detected by direct
immunoblot (due to paucity of their expression and the mixed
cellular nature of brain lysates). However, we investigated the
specific upstream stress or stresses triggering the Fgf21-
inducing cascade as a proxy for their respective ISR arm
activation.
The close apposition of ER and mitochondria favors ER stress
upon loss of proteins involved in mitochondrial and ER
morphology regulation (de Brito and Scorrano, 2008; Mun˜oz
et al., 2013). Drp1 was originally identified as a modulator of
mitochondrial, as well as ER shape (Pitts et al., 1999; Yoon
et al., 1998), suggesting that its deletion might also affect the
ER. Electron microscopy (EM) of hippocampi 4 weeks PTI
revealed that the ER was round and swollen, unlike the flat ER
cisternae in the Drp1flx/flx counterparts (Figure 2A). In addition,
the ER stress marker Bip/GRP78 was upregulated in Drp1iDb/
iDb brains at later stages (Figures 2B and 2C), pointing to a link
between neuronal Drp1 deletion and ER stress activation. As a
proof of principle, when we intraventricularly injected wild-type
mice with the ER stress inducer tunicamycin, we noticed not
only an activated unfolded protein response (UPR), as reflected
by eIF2a phosphorylation and Atf4 elevation, but also an in-
crease in Fgf21 mRNA (Figures 2D–2F), leading to an elevation
in plasma Fgf21 levels (Figure 2G). Altogether, these data indi-
cate that Drp1iDb/iDb brains mount an UPR and that brain ERports 24, 1407–1414, August 7, 2018 1409
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Figure 3. ER Stress-Independent ISR
Branches Contribute to Fgf21 Induction
(A–E) Analysis of TUDCA-treated Drp1-ablated
and control mice.
(A) Representative western blots of hippocampal
lysates of the indicated genotype 10 weeks PTI,
probed for Bip, P-eIF2a, total eIF2a, Atf4, and
actin.
(B and C) Quantification of Bip (B) and phosphor-
ylated elF2a (C) band intensities normalized to
actin (Bip) or total eIF2a, respectively.
(D and E) Hippocampal Fgf21 (D) and Chop (E)
mRNA expression determined by qRT-PCR,
normalized to 18S rRNA ct values. Data represent
average + SEM of at least 4 animals.
(F) Free amino acids in the indicated brain regions
10 weeks PTI. Data represent average ± SEM of at
least 4 animals.
(G) Fold change in selected hits of a total prote-
omics screen 10 weeks PTI, plotted as a function
of the respective q value.
(H) Fold change in selected, iron-related hits of a
proteomics screen 10 weeks PTI.
Asterisks in (E) denote q values (i.e., p values
adjusted for multiple testing): *p < 0.05, **p < 0.01,
***p < 0.001.stress is sufficient to induce local Fgf21 expression and plasma
Fgf21 elevation.
The ER Stress Component Is Dispensable for Fgf21
Induction
To understandwhether ER stresswas necessary to induce Fgf21
expression, we capitalized on the orally bioavailable chemical
chaperone tauroursodeoxycholic acid (TUDCA), which reduces
mitochondria-induced ER stress in flies and mice (Debattisti
et al., 2014; Mun˜oz et al., 2013). Co-treatment of Drp1iDb/iDb
mice with TUDCA and tamoxifen resulted in lower Bip and
P-eIF2a levels, confirming TUDCA bioavailability and activity in
the brain. However, eIF2a phosphorylation and expression of
Fgf21, as well as of the canonical Atf4 target gene Chop, re-
mained elevated in TUDCA-treated Drp1iDb/iDb mice (Figures
3A–3E).1410 Cell Reports 24, 1407–1414, August 7, 2018Overall, although ER stress is present
in Drp1iDb/iDb brains and can cause
Fgf21 expression, its inhibition alone is
not sufficient to abolish Fgf21 in our
model, suggesting that one or more of
the alternative ISR branches contribute
to the observed phenotype.
Impaired Amino Acid and Iron
Metabolism Contributes to ISR-
Driven Fgf21 Induction
To understand which mechanism ac-
counted for Fgf21 production, we
explored the role of the mitochondrial
bioenergetics defect caused by Drp1
ablation (Oettinghaus et al., 2016).However, at 10 weeks PTI, protein levels of Hsp60 and
mRNA levels of Hsp10, ClpP, and Yme1l, markers of the
mtUPR, were normal in Drp1iDb/iDb brains (Figures S3A–S3C).
We confirmed this by an unbiased proteomic analysis on
pooled hippocampi and cortices from mice 10 weeks PTI:
mtUPR was not in place in Drp1iDb/iDb mice, with three of the
five acknowledged mtUPR genes even significantly decreased
(Figure S3D).
Alternatively, ISR could result from a defect in amino acid
biosynthesis or catabolism, both crucially located at the mito-
chondrial level. Total amino acid content was moderately
decreased in the hippocampus, whereas amino acids were
significantly increased in the cortex of Drp1iDb/iDb mice (Fig-
ure 3F). In addition, aminoacyl-tRNA synthetases were
significantly enriched hits of the proteomics analysis of
Drp1iDb/iDb brains. Even more remarkable was the signature
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Figure 4. Brain-Derived Fgf21 Is Induced in
Mouse Models of Neurodegeneration
Data from P301L tau mutant mice (A–D) and
RML prion inoculation disease model (E–H).
(A) Western blot of hippocampi of 9-month-old
P301L mutant mice and age-matched controls.
(B and C) Quantification of Bip (B) and Atf4 (C)
band intensities, normalized to their respective
loading control.
(D) Hippocampal Fgf21 mRNA expression of
9-month-old P301L mutant mice and age-
matched controls, determined by qRT-PCR. Data
represent average + SEM of at least 4 animals.
(E) Western blot of hippocampi of mice intracere-
brally inoculated with RML prions at 10 weeks
postinoculation (wpi).
(F and G) Quantification of Bip (F) and Atf4 (G)
band intensities normalized to their respective
loading control.
(H) Fgf21 transcript levels in hippocampi of normal
brain homogenate (NBH) or RML prion-inoculated
mice at 6, 8, and 10 wpi. Data represent average +
SEM of at least 8 animals.of the subcellular distribution of the altered aminoacyl-tRNA
synthetases: 80% of cytosolic aminoacyl-tRNA synthetases
were significantly upregulated in Drp1iDb/iDb brains, while their
mitochondrial counterparts were mostly downregulated (Fig-
ure 3G). Because heme biosynthesis depends on amino acid
metabolism, as well as on mitochondrial function (Lane et al.,
2015), we next wanted to check its potential involvement in
the phenotype. Ferrochelatase, a rate-limiting mitochondria-
localized component of the heme biosynthetic pathway, was
downregulated in Drp1iDb/iDb mice, as was mitochondrial matrix
iron metabolism regulator frataxin (Figure 3H). Accordingly,
cytosolic iron storage protein ferritin H was upregulated, and
iron importer transferrin receptor was downregulated in
Drp1iDb/iDb brains. Finally, heme-containing hemoglobin was
also strongly downregulated in Drp1iDb/iDb brains (Figure 3H),
reflecting the global changes in iron metabolism caused
by Drp1 ablation. Altogether, these data suggest that bothCell Reamino acid metabolism and heme
biosynthesis are altered upon Drp1 abla-
tion and may contribute to ISR activation
in Drp1iDb/iDb mice.
Brain-Derived Fgf21 Is Induced in
Two Etiologically Distinct Mouse
Models of Neurodegeneration
Wenextwished to investigate the possibil-
ity that Fgf21was induced in clinically rele-
vant models of brain pathologies affecting
mitochondrial dynamics and function.
To this end, we examined tau-mutated
P301Lmice, amodel of frontotemporalde-
mentia (FTD) (Lewis et al., 2000), as well
as the tg37-Rocky Mountain Laboratory
(RML) prion inoculation model (Mallucci
et al., 2003; Moreno et al., 2013). Bothmodels display ISR that responds to PERK inhibition (Moreno
et al., 2013; Radford et al., 2015), as well as defects
in mitochondrial function and transport (Choi et al., 2014; Chou
et al., 2011). In both models, the ER stress and ISR activation
markers Bip, P-eIF2a, and Atf4 were upregulated (Figures 4A–
4C, 4E, and 4F). Fgf21 mRNA was elevated in hippocampi of
P301L, as well as of prion-injected mice at different time points,
also before the onset of symptoms (Figures 4D and 4H). Prion-
inoculated mice orally treated with PERK inhibitor
GSK2606414 showed a demonstrable decrease in Fgf21
expression, confirming that Fgf21 induction is ER stress depen-
dent (Figure 4H). Thus, Fgf21 transcription is induced in etiolog-
ically distinct mouse models of neurodegeneration not caused
by a primarymitochondrial defect. Our data collectively indicate
that Fgf21 might be an early biomarker for neurodegenerative
processes associated with mitochondrial dysfunction and ISR
activation.ports 24, 1407–1414, August 7, 2018 1411
DISCUSSION
Here, we report that Drp1 deletion from adult forebrain neurons
in vivo triggers the activation of amulti-branched stress response
culminating in brain Fgf21 expression. Impaired mitochondrial
function is linked to Fgf21 production in various peripheral
tissues, but not in brain (Cornu et al., 2014; Guridi et al., 2015;
Hagiwara et al., 2012; Keipert et al., 2014; Kim et al., 2013a,
2013b; Touvier et al., 2015; Tyynismaa et al., 2010). In our
system, Drp1 deletion impairs mitochondrial dynamics and ER
morphology and induces ER stress (Figure 2). This could be
due to alterations in mitochondria-ER contacts affecting the
two organellar membranes, modifying membrane curvature
and activating ER stress sensor PERK (Volmer et al., 2013), or
due to direct Drp1 action on ER shape (Yoon et al., 1998). Lack
of rescue by TUDCA treatment (Figures 3A–3E) indicates that
additional stress pathways converging on eIF2a are activated in
the brain upon Drp1 deletion. In particular, heme biosynthesis
and amino acid metabolism, two mitochondria-related path-
ways, are affected by brain Drp1 ablation (Figures 3F–3H).
Heme biosynthesis is a partially mitochondria-resident pathway
that requires iron to be actively imported into the organelles, as
well as amino acids as precursors. Therefore, given the compro-
mised bioenergetic state of Drp1-ablated mitochondria, which
could affect organellar iron import, it is plausible that intra-
mitochondrial steps of heme biosynthesis are impaired. This is
corroborated by the increase in cytosolic ferritin H and the
decrease in transferrin receptor (a signature of high cytosolic
iron) (Muckenthaler et al., 2008). The stark decrease of two
hemoglobin subunits, which would bind heme, is also in line
with the heme deprivation hypothesis (Figure 3H) (Chen, 2007;
Han et al., 2001).
Different brain regions display differential sensitivity to Drp1
deletion, reflecting their individual metabolic needs and re-
sponses (Berthet et al., 2014; Kageyama et al., 2012; Oetting-
haus et al., 2016; Shields et al., 2015). One explanation can lie
in the ability of Atf4 to act with other transcription factors in a
combinatorial manner based on the nature of the stress (Kilberg
et al., 2009). Total amino acid concentration varied drastically
between hippocampus and cortex (Figure 3F), which could be
linked to the presence, in the anterior piriform cortex, of the
body’s amino acid deficiency sensor (Anthony and Gietzen,
2013). It is therefore conceivable that the differential sensitivity
to Drp1 ablation is linked to the different degrees of amino acid
concentration changes within the brain.
The importance of Fgf21 as a proxy of brain mitochondrial de-
fects is reinforced by the finding that Fgf21 is expressed in brains
of prion-inoculated mice, as well as of mice carrying the FTD-
associated P301L tau mutation (Figures 4D and 4H). Similar to
Drp1-deleted mice, both models display defects in mitochon-
drial function and transport, as well as ER stress-dependent
ISR activation that can be reversed by PERK blockage (Chou
et al., 2011; Radford et al., 2015). Although dysregulated iron
and heme have also been linked to tau accumulation and prion
diseases (Belaidi and Bush, 2016; Singh, 2014), ISR activation
in these models is exclusively PERK dependent, which makes
them an ideal model to study the reversal of Fgf21 expression
by GSK2606414.1412 Cell Reports 24, 1407–1414, August 7, 2018Fgf21 is regulated by circadian and nutritional factors (Fisher
and Maratos-Flier, 2016; Kharitonenkov and DiMarchi, 2017),
potentially limiting the specificity of its detection in vivo as a
biomarker of neuronal mitochondrial dysfunction. In particular,
liver Fgf21 production is modulated by diverse dietary manipula-
tions beyond fasting (Fisher and Maratos-Flier, 2016). For these
reasons, the exploration of Fgf21 levels in patients’ samples was
beyond the scope of this work. Nevertheless, in light of our find-
ings and of Fgf21 being a biomarker of mitochondrial myopa-
thies, we encourage clinicians to explore this possibility in exist-
ing, appropriately controlled patient cohorts. Of course,
confounding factors such as diabetes, obesity, or liver disease
shall be carefully considered. To this end, cerebrospinal fluid
(CSF) analyses might prove relevant, although at least upon its
acute peripheral injection in mice, this cytokine can also cross
the BBB (Douris et al., 2015; Hsuchou et al., 2007).
Future work grounded in the discoveries reported here will test
whether Fgf21 is induced in other diseases sharing mitochon-
drial and ER stress components, like Parkinson’s disease and
disorders of the amyotrophic lateral sclerosis/FTD spectrum
(Stoica et al., 2014; Wang et al., 2016a, 2016b). While we do
not expect Fgf21 to aid in the diagnostic discrimination of
different neurodegenerative entities, we can predict that our dis-
covery of a secreted, brain-derived factor induced in etiologically
diverse CNS diseaseswould represent amuch-needed progress
in presymptomatic screening, within a combined framework of
validated biomarkers and predictive algorithms.
In conclusion, our work shows that neurons sense dysregu-
lated mitochondrial dynamics and ER stress to activate a multi-
branched stress response culminating in the release of Fgf21.
The same Fgf21 mitokine is produced in the brains of bona fide
tauopathy and prion disease mouse models, highlighting its po-
tential as a marker of brain mitochondrial dysfunction.
EXPERIMENTAL PROCEDURES
For more details, refer to the Supplemental Experimental Procedures.
Mice
Drp1iDb/iDb and tau mutant (P301L) mice were described previously (Oetting-
haus et al., 2016; Lewis et al., 2000; Radford et al., 2015). For the prion disease
model, hemizygous tg37 mice inoculated with RML prion were used (Mallucci
et al., 2003; Moreno et al., 2013).
Western Blot
Lysates of perfused mouse brains were analyzed as previously described
(Oettinghaus et al., 2016). Antibodies are listed in Supplemental Experimental
Procedures.
Real-Time PCR
Organs were collected from PBS-perfused mice and RNA was isolated
(RNeasy kits 74104, 74704, and 74804). RT-PCR was performed using the
High Capacity cDNA Reverse Transcription Kit (Invitrogen, 4368814). Real-
time PCR was performed using TaqMan assays (Life Technologies) on a
7900HT Real-Time PCR System (Applied Biosystems). TaqMan assays are
listed in Supplemental Experimental Procedures. Cross-threshold (ct) values
were normalized to 18S ct values.
Fluorescent Detection of Fgf21 mRNA
This analysis was performed as a service by Advanced Cell Diagnostics with
the RNAscope technology, following the standard manufacturer’s protocol.
ELISA
Blood was collected between 9 and 10 a.m., and plasma Fgf21 levels
were analyzed according to the manufacturer’s instructions (BioVendor,
RD291108200R).
Quantitative Proteomics
Details on this analysis were described previously (Oettinghaus et al., 2016).
Data are available via ProteomeXchange: PXD004890.
Statistics
Data analysis was performed with GraphPad Prism 6. For statistical analyses,
two-tailed Student’s t test and one-way ANOVAwith Sidak’s multiple compar-
ison corrections were used. Unless otherwise specified, asterisks denote
p values of an unpaired, two-tailed Student’s t test: *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at https://doi.org/
10.1016/j.celrep.2018.07.023.
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SUPPLEMENTARY EXPERIMENTAL PROCEDURES 
Mice. Generation of tamoxifen-inducible, forebrain neuron-specific Drp1flx/flx Cre+ mice was described 
recently (Oettinghaus et al., 2016). At 8 weeks of age recombination of the floxed loci was induced by 
tamoxifen injection (Sigma Aldrich, Germany; 1mg twice daily for 5 consecutive days). For genotyping, 
genomic DNA was isolated from tail tips by proteinase K digestion (Sigma Aldrich, Germany). CreERT2 
transgene was amplified using the following primers: 5' GGT TCT CCG TTT GCA CTC AGG A 3', 5' CTG 
CAT GCA CGG GAC AGC TCT 3', 5' GCT TGC AGG TAC AGG AGG TAG T 3'. Recombination of the 
Drp1 locus was detected using the following primers: 5' CAG CTG CAC TGG CTT CAT GAC TC 3', 5' TGC 
CAA GAA TGA TTA CAG TCA GG 3'.  
Mutant tau (P301L) and prion-injected (RML) mice have been described elsewhere (Moreno et al., 2013; 
Radford et al., 2015). When indicated, mice were treated orally with PERK inhibitor GSK2606414 (50mg/kg, 
three doses, starting at 10 wpi; Moreno et al., 2013). 
For intraventricular tunicamycin microinjections, mice were anaesthetized by i.p. injection of 10 mg/kg 
ketamine and 20 mg/kg xylazine. Injections were performed with a 10 µl Hamilton microsyringe as described 
(Ono et al., 2012) using -0.5 mm posterior, -1.0 mm lateral, -2.0 mm inferior relative to bregma as coordinates. 
2 µl of 0.1 µg/µl tunicamycin in 1% DMSO or 2 µl vehicle were carefully injected over the course of 2 min 
and the needle left in place for 5 min before retraction. Following scalp suture mice were monitored until 
recovery from anesthesia. After 48h, mice were sacrificed, their hippocampi dissected and plasma collected 
(between 9 and 10 AM).  
TUDCA treatment was initiated at day 1 PTI. Mice were fed 0.4% TUDCA-supplemented chow (chow: ssniff, 
Germany; TUDCA: Merck, UK) for 7 weeks.  
All experiments were performed under specific pathogen-free conditions, in accordance with Swiss animal 
protection legislation and with approval of the Basel Veterinary Committee for Animal Care (permits 2393, 
23288). 
  
Western Blot. Lysates of perfused mouse brains were analyzed as previously described (Oettinghaus et al., 
2016). Membranes were probed with the following antibodies: Drp1 (BD Biosciences; 611112), Atf4 (Santa 
Cruz; sc-200), Bip (BD Biosciences; 610978), eIF2α total (Cell Signaling Technology, #5324), eIF2α 
phospho-Ser51 (Cell Signaling Technology, #3398), Hsp60 (Enzo; ADI-SPA-807-E), actin (Thermo 
Scientific; MA1-91399), GAPDH (Abnova; H00002597-M03) and beta-tubulin (Sigma; T8660). Secondary 
antibodies were anti mouse-HRP (GE Healthcare; NA931) and anti-rabbit-HRP (GE Healthcare; NA934); for 
signal detection Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare; RPN2232) was 
used in conjunction with Amersham Hyperfilm (GE Healthcare; 28-9068-44), or with an Azure C300 imager 
(Azure Biosystems, USA). Densitometry was performed using ImageJ. 
  
Histology and immunohistochemistry. Following transcardial formaldehyde perfusion of anaesthetized mice, 
histological assessment was performed using previously described protocols (Oettinghaus et al., 2016).  
In brief, coronal hippocampal sections (4 µm) were prepared from formalin-fixed, paraffin-embedded (FFPE) 
wildtype mouse brain and hematoxylin-eosin stained using standard protocols. In addition, FFPE sections were 
subjected to immunohistochemistry using anti-GFAP (DAKO; 1:500), anti-NeuN (Chemicon; 1:200), and anti-
Iba1 (Wako; 1:3000); secondary antibody was anti-rabbit IgG (Vector; ImmPRESS Reagent Kit). All 
immunohistochemical stains were performed on an automated Ventana immunostaining instrument using 
prediluted antibodies (Ventana Medical Systems Inc.). 
 
Fluorescent detection of Fgf21 mRNA.  This analysis was performed as a service by Advanced Cell 
Diagnostics, Inc. with the RNAscope technology, following standard manufacturer’s protocol. Briefly, frozen 
mouse brain sections (10µm) were stained with probes targeting Fgf21, Aldh1l1 (astrocytes) and RBfox3 (also 
known as NeuN, neurons) mRNAs. POLR2A/PPIB/UBC were used as a positive control marker for sample 
quality control and to evaluate RNA quality in both tissue samples. Bacterial gene dapB was used as a negative 
control. Images were acquired on a Zeiss LSM 510 Meta confocal microscope. 
For quantification of Fgf21 signal, Fgf21-positive area/ total area was employed within the CA1 region. 
Briefly, images were thresholded and analyzed with the “analyze particles” function on ImageJ within an 
indicated ROI corresponding to the CA1 region. 
 
Ultrastructural analyses. Transmission electron microscopy was performed as previously described 
(Oettinghaus et al., 2016) using a Phillips CM100 transmission electron microscope.  
 
Real-time PCR. Organs were collected from PBS-perfused mice and RNA was isolated (RNeasy Lipid Tissue 
Kit for adipose tissue, 74804; RNeasy Fibrous Tissue kit for muscle, 74704; RNeasy kit for other organs, 
74104; all from Qiagen). Reverse-transcriptase PCR was performed using the High Capacity cDNA Reverse 
Transcription Kit (Invitrogen; 4368814). Real-time PCR was performed using TaqMan assays (Life 
Technologies) on a 7900HT Real-Time PCR System (Applied Biosystems). The following Taqman assays 
were used: FGF21 (Mm00840165_g1), 18S (Mm03928990_g1), Chop (Mm01135937_g1), PPARα 
(m00440939_m1), PPARδ (Mm00803184_m1), PGC-1α (Mm01208835_m1), PGC-1β (Mm00504720_m1), 
ATF4 (Mm00515325_g1), Akt1 (Mm01331626_m1), PI3K (Mm00803160_m1), Hsp10 (Mm00434083_m1), 
Clpp (Mm00489940_m1), Yme1l1 (Mm00496843_m1). Cross-threshold (ct) values were normalized to 18S ct 
values. 
 
ELISA and other kits. Blood was collected between 9 and 10 AM in EDTA-coated tubes and hormone levels 
were detected by ELISA from plasma (FGF21: BioVendor, RD291108200R). Total amino acids were 
measured on hippocampi, cortices and cerebella 10 weeks PTI with the L-Amino Acid Quantitation Kit 
(MAK002, Sigma Aldrich, Germany) according to manufacturer’s instructions. 
 
Proteomics. In Fig. S2B, P-values denote likelihood of protein group being a random sample of the total 
population of detected proteins (Fisher’s exact test). Reference dataset was obtained from (Han et al., 2013). 
  
  
SUPPLEMENTARY FIGURE LEGENDS 
Fig. S1 Cytoarchitecture of hippocampal pyramidal layer, related to Fig. 1C 
(A-E) Coronal cross-sections of hippocampal CA1 region stained with hematoxylin/eosin (A, B) or probed by 
immunohistochemistry for NeuN (C; neuronal), GFAP (D; astroglia), and Iba1 (E; microglia). Scale bars: 
50µm (A), 20µm (B-E) 
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Fig. S2 Atf4 expression and target gene activation in Drp1-ablated brains, related to Fig. 1E-H 
 
(A) mRNA expression in Drp1-ablated and control animals at 10 weeks PTI, normalized against 18S rRNA ct 
values. Data represent average ±SEM of at least 4 animals. 
(B) Pie chart representing frequency distribution of up- and downregulated proteins of Drp1-ablated forebrain 
compared to wild-type brain.  
 
  
Fig. S3 The mitochondrial UPR is not activated in Drp1-ablated brains, related to Fig. 3F-H 
 
(A, B) Protein expression of mtUPR marker Hsp60 as determined by Western blot on hippocampal lysates at 
10 weeks PTI, normalized to actin. Data represent average ±SEM of at least 4 animals. 
(C) Hippocampal mRNA expression of Hsp10, ClpP, and Yme1l 10 weeks PTI as determined by qRT-PCR, 
normalized to 18S rRNA ct values. Data represent average ±SEM of at least 4 animals. 
(D) Fold change in selected, mtUPR-related hits of a total proteomics screen 10 weeks PTI. 
Asterisks in (D) denote q-values (i.e. p-values adjusted for multiple testing): *: p<0.05, ***: p<0.001.  
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